Nimotuzumab (BIOMAb EGFR Biocon India; TheraCIM CIMYM Biosciences Canada; Theraloc Oncoscience Europe CIMAher Center of Molecular Immunology Havana Cuba) is a humanized monoclonal antibody used to treat squamous cell carcinomas […]
List of articles in "Drug" category - Page 363
Matuzumab
Matuzumab (formerly EMD 72000) is a humanized monoclonal antibody for the treatment of cancer. It binds to the epidermal growth factor receptor (EGFR) with high affinity.
Lintuzumab
Lintuzumab (SGN-33) is a humanized monoclonal antibody used in the treatment of cancer. The drug had been developed by Seattle Genetics as a treatment for acute myeloid leukemia (AML) a […]
Inotuzumab ozogamicin
Inotuzumab ozogamicin (CMC-544) is an antibody-drug conjugate for the treatment of cancers. It consists of the humanized monoclonal antibody inotuzumab (for CD22) linked to a cytotoxic agent from the class […]
Motavizumab
Motavizumab (proposed INN trade name Numax) is a humanized monoclonal antibody. It is being investigated by MedImmune (today a subsidiary of AstraZeneca) for the prevention of respiratory syncytial virus infection […]
Cyprazepam
Cyprazepam is a drug which is a sedative-hypnotic benzodiazepine derivative. It has anxiolytic properties and presumably also has hypnotic skeletal muscle relaxant anticonvulsant and amnestic properties.
Haloxazolam
Haloxazolam (marketed in Japan under the brand name Somelin) is a drug which is a benzodiazepine derivative. It has similar hypnotic properties as the benzodiazepine drugs triazolam temazepam and flunitrazepam […]
Pentoxyverine
Pentoxyverine (rINN) or carbetapentane is an antitussive (cough suppressant) commonly used for cough associated with illnesses like common cold. It is sold over-the-counter in the United States as Solotuss or […]
Felvizumab
Felvizumab is a humanized monoclonal antibody against respiratory syncytial virus.
Tuvirumab
Tuvirumab is a human monoclonal antibody for the treatment of patients with chronic hepatitis B. It has undergone Phase I clinical trials in 2001.